Skip to main content

NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars

Clinical-stage immunotherapy company Nantkwest Inc NK reports positive interim data on survival rates in the Metastatic Pancreatic Cancer QUILT 88 trial on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.